NCT02591901View on ClinicalTrials.gov

Preventing UTIs in Chronic Neurogenic Bladder Dysfunction (Mix Methods)

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 6, 2018

Primary Completion Date

August 2, 2019

Study Completion Date

September 21, 2019

Conditions
UTINeurogenic BladderAntibiotic Resistance
Interventions
DRUG

Uro vaxom

Prevention of recurrent symptomatic lower urinary tract infections

OTHER

Placebo comparator

Placebo comparator

Trial Locations (2)

HP21 8AL

Stoke Mandeville Hospital, Aylesbury

Unknown

Oxford Centre for Enablement, Oxford

Sponsors
All Listed Sponsors
collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

collaborator

Oxford Clinical Trials Research Unit

UNKNOWN

lead

Buckinghamshire Healthcare NHS Trust

OTHER

NCT02591901 - Preventing UTIs in Chronic Neurogenic Bladder Dysfunction (Mix Methods) | Biotech Hunter | Biotech Hunter